世界のシムリン（プラムリンチド）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Symlin (pramlintide) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14439 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、シムリン（プラムリンチド）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。シムリン（プラムリンチド）の種類別市場規模（1.5mlペン注射器、2.7mlペン注射器）、用途別市場規模（I型糖尿病、II型糖尿病）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・シムリン（プラムリンチド）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：1.5mlペン注射器、2.7mlペン注射器 ・用途別分析2016年-2026年：I型糖尿病、II型糖尿病 ・シムリン（プラムリンチド）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・シムリン（プラムリンチド）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・シムリン（プラムリンチド）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・シムリン（プラムリンチド）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・シムリン（プラムリンチド）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Symlin (pramlintide) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Symlin (pramlintide) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Symlin (pramlintide) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Symlin (pramlintide) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
1.5ml pen-injector
2.7ml pen-injector

Market segment by Application, can be divided into
Type I diabetes
Type II diabetes

Market segment by players, this report covers
AstraZeneca

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Symlin (pramlintide)
1.2 Classification of Symlin (pramlintide) by Type
1.2.1 Overview: Global Symlin (pramlintide) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Symlin (pramlintide) Revenue Market Share by Type in 2020
1.2.3 1.5ml pen-injector
1.2.4 2.7ml pen-injector
1.3 Global Symlin (pramlintide) Market by Application
1.3.1 Overview: Global Symlin (pramlintide) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Type I diabetes
1.3.3 Type II diabetes
1.4 Global Symlin (pramlintide) Market Size & Forecast
1.5 Global Symlin (pramlintide) Market Size and Forecast by Region
1.5.1 Global Symlin (pramlintide) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Symlin (pramlintide) Market Size by Region, (2016-2021)
1.5.3 North America Symlin (pramlintide) Market Size and Prospect (2016-2026)
1.5.4 Europe Symlin (pramlintide) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Symlin (pramlintide) Market Size and Prospect (2016-2026)
1.5.6 South America Symlin (pramlintide) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Symlin (pramlintide) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Symlin (pramlintide) Market Drivers
1.6.2 Symlin (pramlintide) Market Restraints
1.6.3 Symlin (pramlintide) Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Symlin (pramlintide) Product and Solutions
2.1.4 AstraZeneca Symlin (pramlintide) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Symlin (pramlintide) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Symlin (pramlintide) Players Market Share
3.2.2 Top 10 Symlin (pramlintide) Players Market Share
3.2.3 Market Competition Trend
3.3 Symlin (pramlintide) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Symlin (pramlintide) Revenue and Market Share by Type (2016-2021)
4.2 Global Symlin (pramlintide) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Symlin (pramlintide) Revenue Market Share by Application (2016-2021)
5.2 Symlin (pramlintide) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Symlin (pramlintide) Revenue by Type (2016-2026)
6.2 North America Symlin (pramlintide) Revenue by Application (2016-2026)
6.3 North America Symlin (pramlintide) Market Size by Country
6.3.1 North America Symlin (pramlintide) Revenue by Country (2016-2026)
6.3.2 United States Symlin (pramlintide) Market Size and Forecast (2016-2026)
6.3.3 Canada Symlin (pramlintide) Market Size and Forecast (2016-2026)
6.3.4 Mexico Symlin (pramlintide) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Symlin (pramlintide) Revenue by Type (2016-2026)
7.2 Europe Symlin (pramlintide) Revenue by Application (2016-2026)
7.3 Europe Symlin (pramlintide) Market Size by Country
7.3.1 Europe Symlin (pramlintide) Revenue by Country (2016-2026)
7.3.2 Germany Symlin (pramlintide) Market Size and Forecast (2016-2026)
7.3.3 France Symlin (pramlintide) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Symlin (pramlintide) Market Size and Forecast (2016-2026)
7.3.5 Russia Symlin (pramlintide) Market Size and Forecast (2016-2026)
7.3.6 Italy Symlin (pramlintide) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Symlin (pramlintide) Revenue by Type (2016-2026)
8.2 Asia-Pacific Symlin (pramlintide) Revenue by Application (2016-2026)
8.3 Asia-Pacific Symlin (pramlintide) Market Size by Region
8.3.1 Asia-Pacific Symlin (pramlintide) Revenue by Region (2016-2026)
8.3.2 China Symlin (pramlintide) Market Size and Forecast (2016-2026)
8.3.3 Japan Symlin (pramlintide) Market Size and Forecast (2016-2026)
8.3.4 South Korea Symlin (pramlintide) Market Size and Forecast (2016-2026)
8.3.5 India Symlin (pramlintide) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Symlin (pramlintide) Market Size and Forecast (2016-2026)
8.3.7 Australia Symlin (pramlintide) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Symlin (pramlintide) Revenue by Type (2016-2026)
9.2 South America Symlin (pramlintide) Revenue by Application (2016-2026)
9.3 South America Symlin (pramlintide) Market Size by Country
9.3.1 South America Symlin (pramlintide) Revenue by Country (2016-2026)
9.3.2 Brazil Symlin (pramlintide) Market Size and Forecast (2016-2026)
9.3.3 Argentina Symlin (pramlintide) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Symlin (pramlintide) Revenue by Type (2016-2026)
10.2 Middle East & Africa Symlin (pramlintide) Revenue by Application (2016-2026)
10.3 Middle East & Africa Symlin (pramlintide) Market Size by Country
10.3.1 Middle East & Africa Symlin (pramlintide) Revenue by Country (2016-2026)
10.3.2 Turkey Symlin (pramlintide) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Symlin (pramlintide) Market Size and Forecast (2016-2026)
10.3.4 UAE Symlin (pramlintide) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Symlin (pramlintide) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Symlin (pramlintide) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Symlin (pramlintide) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Symlin (pramlintide) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Symlin (pramlintide) Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Symlin (pramlintide) Product and Solutions
Table 9. AstraZeneca Symlin (pramlintide) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Symlin (pramlintide) Revenue (USD Million) by Players (2019-2021)
Table 11. Global Symlin (pramlintide) Revenue Share by Players (2019-2021)
Table 12. Breakdown of Symlin (pramlintide) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Symlin (pramlintide) Players Head Office, Products and Services Provided
Table 14. Symlin (pramlintide) Mergers & Acquisitions in the Past Five Years
Table 15. Symlin (pramlintide) New Entrants and Expansion Plans
Table 16. Global Symlin (pramlintide) Revenue (USD Million) by Type (2016-2021)
Table 17. Global Symlin (pramlintide) Revenue Share by Type (2016-2021)
Table 18. Global Symlin (pramlintide) Revenue Forecast by Type (2021-2026)
Table 19. Global Symlin (pramlintide) Revenue by Application (2016-2021)
Table 20. Global Symlin (pramlintide) Revenue Forecast by Application (2021-2026)
Table 21. North America Symlin (pramlintide) Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Symlin (pramlintide) Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Symlin (pramlintide) Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Symlin (pramlintide) Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Symlin (pramlintide) Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Symlin (pramlintide) Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Symlin (pramlintide) Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Symlin (pramlintide) Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Symlin (pramlintide) Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Symlin (pramlintide) Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Symlin (pramlintide) Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Symlin (pramlintide) Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Symlin (pramlintide) Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Symlin (pramlintide) Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Symlin (pramlintide) Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Symlin (pramlintide) Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Symlin (pramlintide) Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Symlin (pramlintide) Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Symlin (pramlintide) Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Symlin (pramlintide) Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Symlin (pramlintide) Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Symlin (pramlintide) Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Symlin (pramlintide) Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Symlin (pramlintide) Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Symlin (pramlintide) Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Symlin (pramlintide) Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Symlin (pramlintide) Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Symlin (pramlintide) Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Symlin (pramlintide) Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Symlin (pramlintide) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Symlin (pramlintide) Picture
Figure 2. Global Symlin (pramlintide) Revenue Market Share by Type in 2020
Figure 3. 1.5ml pen-injector
Figure 4. 2.7ml pen-injector
Figure 5. Symlin (pramlintide) Revenue Market Share by Application in 2020
Figure 6. Type I diabetes Picture
Figure 7. Type II diabetes Picture
Figure 8. Global Symlin (pramlintide) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Symlin (pramlintide) Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Symlin (pramlintide) Revenue Market Share by Region (2016-2026)
Figure 11. Global Symlin (pramlintide) Revenue Market Share by Region in 2020
Figure 12. North America Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Symlin (pramlintide) Market Drivers
Figure 18. Symlin (pramlintide) Market Restraints
Figure 19. Symlin (pramlintide) Market Trends
Figure 20. AstraZeneca Recent Developments and Future Plans
Figure 21. Global Symlin (pramlintide) Revenue Share by Players in 2020
Figure 22. Symlin (pramlintide) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 23. Global Top 3 Players Symlin (pramlintide) Revenue Market Share in 2020
Figure 24. Global Top 10 Players Symlin (pramlintide) Revenue Market Share in 2020
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 26. Global Symlin (pramlintide) Revenue Share by Type in 2020
Figure 27. Global Symlin (pramlintide) Market Share Forecast by Type (2021-2026)
Figure 28. Global Symlin (pramlintide) Revenue Share by Application in 2020
Figure 29. Global Symlin (pramlintide) Market Share Forecast by Application (2021-2026)
Figure 30. North America Symlin (pramlintide) Sales Market Share by Type (2016-2026)
Figure 31. North America Symlin (pramlintide) Sales Market Share by Application (2016-2026)
Figure 32. North America Symlin (pramlintide) Revenue Market Share by Country (2016-2026)
Figure 33. United States Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Canada Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Mexico Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Europe Symlin (pramlintide) Sales Market Share by Type (2016-2026)
Figure 37. Europe Symlin (pramlintide) Sales Market Share by Application (2016-2026)
Figure 38. Europe Symlin (pramlintide) Revenue Market Share by Country (2016-2026)
Figure 39. Germany Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. France Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. United Kingdom Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Russia Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Italy Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Symlin (pramlintide) Sales Market Share by Type (2016-2026)
Figure 45. Asia-Pacific Symlin (pramlintide) Sales Market Share by Application (2016-2026)
Figure 46. Asia-Pacific Symlin (pramlintide) Revenue Market Share by Region (2016-2026)
Figure 47. China Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Japan Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. South Korea Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. India Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Southeast Asia Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Australia Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South America Symlin (pramlintide) Sales Market Share by Type (2016-2026)
Figure 54. South America Symlin (pramlintide) Sales Market Share by Application (2016-2026)
Figure 55. South America Symlin (pramlintide) Revenue Market Share by Country (2016-2026)
Figure 56. Brazil Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Argentina Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Middle East and Africa Symlin (pramlintide) Sales Market Share by Type (2016-2026)
Figure 59. Middle East and Africa Symlin (pramlintide) Sales Market Share by Application (2016-2026)
Figure 60. Middle East and Africa Symlin (pramlintide) Revenue Market Share by Country (2016-2026)
Figure 61. Turkey Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Saudi Arabia Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. UAE Symlin (pramlintide) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source

---